Greenwich LifeSciences
GLSI
$11.55
Share price
-0.17%
Change (1 day)
-25.48%
Change (1 year)
Categories
EPS for Greenwich LifeSciences (GLSI)
EPS in 2025 (TTM): -$0.84
According to Greenwich LifeSciences's latest financial reports the company's current EPS (TTM) is -$0.84. In 2023 the company made an earnings per share (EPS) of -$0.69 a decrease over its 2022 EPS that were of -$0.61.
EPS history for Greenwich LifeSciences from 2018 to 2025
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2025 (TTM) | -$0.84 | |
| 2023 | -$0.69 | 13.11% |
| 2022 | -$0.61 | 74.29% |
| 2021 | -$0.35 | 75% |
| 2020 | -$0.20 | -30.11% |
| 2019 | -$0.29 | 102.72% |
| 2018 | -$0.14 |
EPS for similar companies or competitors
| Company | EPS | EPS differencediff. | Country |
|---|---|---|---|
 Novocure
NVCR | -$1.51 | 79.76% | Jersey |
 Novavax NVAX | $3.04 | -461.90% | 🇺🇸 USA |
 Organovo ONVO | -$11.52 | 1,271.43% | 🇺🇸 USA |
 Orchard Therapeutics
ORTX | -$7.10 | 745.24% | 🇬🇧 UK |